Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Updated Patient Registry, Drug Development Progress, & More!
This month, significant strides have been made in addressing rare liver disease care. Updates to patient registries, novel therapeutic options, and strategies for expediting prior authorizations in rare diseases are highlighted below.
Recognizing Liver Cancer Awareness Month!
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world.
Global Communities Rally around Third Deadliest Cancer – Liver Cancer
(Washington, D.C., October 1, 2023) – Today marks the start of Liver Cancer Awareness Month, which will feature the monthlong #OctoberIs4Livers multifaceted campaign led by Global Liver Institute (GLI) to promote awareness of the disease, mark progress made, and identify key areas of global focus to make improvements for liver cancer patients. In addition to a comprehensive social media campaign, “Liver Cancer Lessons” education series, and featured conversations with expert guests and GLI CEO Donna R. Cryer, JD, partners around the world will host Open House events to inform and advocate to fight liver disease in their communities.
The Latest at GLI: Reasons for Celebration! 🎊
As we turn the corner into the fall 🍂 (or spring🌸, for our southern hemisphere friends), there is much to celebrate and much to accomplish in the last few months of the year.
Global Liver Institute Thanks President Biden for Signing the Securing the U.S. Organ Procurement and Transplantation Network Act into Law
Washington, DC, September 27, 2023 – On Friday, September 22, 2023 President Joseph Biden signed the Securing the U.S. Organ Procurement and Transplantation Network (OPTN) Act into law – which was previously passed by Congress in July.
Tackling Fatty Liver Disease
As the field of NASH is on the verge of clinical and diagnostic breakthroughs, discover how GLI is promoting healthier living through our personalized nutrition solution, advocating for greater inclusion in clinical trials, and recognizing the role of drug safety and efficacy.
A Busy Fall of Legislative and Regulatory Activity
During the Congressional recess in August, GLI prepared for a busy fall. Congress returns in September to advance appropriations bills and debate key legislative priorities.
Advancements in the Liver Cancer Landscape
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world.
Addressing Unmet Needs in Peds and Rare Liver Diseases
Concerted efforts are driving positive change in the pediatric and rare liver disease community! Read on for details:
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases
Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as director of the National Institute of Allergy and Infectious Diseases (NIAID) by the acting director of the NIH. Dr. Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America.
Technology at Work
Read along for some updates about cutting-edge technology in rare liver disease that should improve prompt diagnosis, ongoing feedback, and effective interventions.
GLI Leads Charge for Common-Sense Policies to Advance High Quality Care for Everyone
In July, GLI used its voice to challenge policymakers to take steps to advance high quality, equitable care for everyone.